Vitamin D supplements might slow cellular aging by preventing the loss of telomeres, DNA sequences at the ends of chromosomes that shorten in old age, a new study suggests. The health effects of these findings aren’t yet clear.

Vitamin D had been touted as a panacea for a number of health conditions, from cardiovascular disease to bone loss. In 2020 a large randomized controlled trial of supplementation instead found benefits only in a few conditions, particularly autoimmune disease and advanced cases of cancer, says the new study’s co-author JoAnn Manson, a professor of medicine at Harvard Medical School and a principal investigator of that large trial, called the VITamin D and OmegA-3 TriaL (VITAL). The new study is an analysis of data from VITAL. Its finding could explain the protective effect of vitamin D supplements on these specific aging-related diseases, Manson says.

 “If is replicated in another randomized trial of vitamin D supplements, I think this could translate into clinical effects for chronic diseases of aging,” she says. “We’re already seeing that vitamin D does reduce inflammation; it reduces advanced cancers and cancer deaths, as well as autoimmune diseases. This could provide a biological mechanism.”
 
To read more, click here.